News

Patient and physician demographics were not significantly associated with discordance.

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and National Psoriasis Foundations President and CEO Leah Howard, JD, discusses the importance of advocacy and mental health in chronic skin conditions.

David Mandell, JD, MBA, is here to help ensure new and novice clinicians understand the impact of taxes, lifestyle creep, investment plans, and more.

A combined treatment regimen of encorafenib and binimetinib led to improved progression-free survival, overall response rate, and tolerability in patients with advanced BRAF-mutant melanoma.

UV exposure or trauma to the skin, such as blistering and ulceration, can lead to changes in skin pigmentation and appearance. 

Total dose and number of cycles of rituximab were not associated with duration or severity of COVID-19 disease.

Patients with the DecisionDx-Melanoma 31-gene expression profile test had a 29% lower melanoma-specific survival mortality.

The DERMACLEAR study has retrospectively obtained data from more than 54,000 patients, and the NLP system had greater than 95% precision.

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.

In this month's Legal Eagle, learn what clinicians are required to disclose about their personal health ahead of performing procedures.

A Zurich case series is demonstrating the efficacy of dupilumab injections in patients with inflammation and chronic prurigo.

ABO blood type appeared to be a factor in severity of acne vulgaris.

Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.

Researchers found that STAT3 could be activated, and inhibition could be achieved in patients with hypertrophic scarring.

While the linkage between squamous cell cancers and genital lichen sclerosus has been well-established, fewer studies have examined the associations between penile melanomas in males.

In this week’s Pointers With Portela, the 208SkinDoc answers frequently asked questions about microneedling and its benefits.

This Psoriasis Awareness Month, Dermatology Times is looking back at the treatment and research landscape of 2023.

In part 2 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

The results showed that minoxidil with laser resulted in a slightly better dermoscopy score than minoxidil alone.

Results showed that the hybrid filler significantly increased collagen fibers with minimal adverse events.

The study is the first large study to assess skin cancer screening efforts aimed at volunteer firefighters in the US.

Piction Health Dermatology seeks to break down barriers in dermatologic care access.

This week’s collection of the latest dermatologic studies covers distinguishing between granular cell tumors and melanoma, methotrexate and biologics for anxiety and depression among PsO patients, botulinum toxin for scalp conditions, and a review of the SPRING study for guselkumab.

Female sex bias in hidradenitis suppurativa can be attributed to several contributing immunological factors.

As your youngest patients begin the return to the classroom, pediatric dermatologist Latanya Benjamin, MD, FAAD, FAAP, offers perspectives in education and skin care tips.

Mannitol and ectoine, when used with UV filters in sunscreen, can provide a higher level of skin protection.

Patients with episodes longer than 4 years had a delayed response rate.

This Hair Loss Awareness Month, test your knowledge of hair loss conditions. Click here to answer this week's poll.

Dermatology Times Editor in Chief Zoe Diana Draelos, MD, reflects on the importance of dermatology residency programs in cultivating early passion for the specialty.

In part 1 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the pathogenesis of acne vulgaris, the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.